GUANGZHOU XUJOHN BIO-TECHNIQUE CO., LTD – Trademark Portfolio

Entity Type: 99

GUANGZHOU XUJOHN BIO-TECHNIQUE CO., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SPODARE. The owner is based in GUANGZHOU.

HUANGPU DISTRICT

NO.1 BUILDING, THE 7TH YARD, LIANDA ROAD

GUANGZHOU 510700 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SPODARE
SPODARE
Registered 2024

Trademark Classifications

GUANGZHOU XUJOHN BIO-TECHNIQUE CO., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does GUANGZHOU XUJOHN BIO-TECHNIQUE CO., LTD have?

GUANGZHOU XUJOHN BIO-TECHNIQUE CO., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does GUANGZHOU XUJOHN BIO-TECHNIQUE CO., LTD file in?

GUANGZHOU XUJOHN BIO-TECHNIQUE CO., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 3 (Cosmetics & Cleaning). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are GUANGZHOU XUJOHN BIO-TECHNIQUE CO., LTD's most well-known trademarks?

GUANGZHOU XUJOHN BIO-TECHNIQUE CO., LTD's registered trademark portfolio includes well-known marks such as SPODARE. These are among 1 currently registered trademark in the portfolio.

What is GUANGZHOU XUJOHN BIO-TECHNIQUE CO., LTD's trademark registration success rate?

GUANGZHOU XUJOHN BIO-TECHNIQUE CO., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.